The leading cancer hospital urges carrier screening to prevent thalassemia burden
The company has also launched Elyara, a portfolio of products in regenerative medical aesthetics focused on non-invasive skin and hair restoration
Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
The company allocated €56 million to research and development for next-generation line solutions
Subscribe To Our Newsletter & Stay Updated